Notoginsenoside R1 Ameliorate High-Fat-Diet and Vitamin D3-Induced Atherosclerosis via Alleviating Inflammatory Response, Inhibiting Endothelial Dysfunction, and Regulating Gut Microbiota

References

• Li F, Zhang T, He Y, et al. Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE-/-mice. J Ethnopharmacol. 2020;247:112232. doi:10.1016/j.jep.2019.112232
   PubMed Web of Science ®Google Scholar
• Xu S, Ilyas I, Little PJ, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: from Mechanism to Pharmacotherapies. Pharmacol Rev. 2021;73(3):924–967. doi:10.1124/pharmrev.120.000096
   PubMed Web of Science ®Google Scholar
• Ma L, Zhao Z, Zhao Y, Gao Y, Zhao L, Li S. Weizmannia coagulans JA845 improves atherosclerosis induced by vitamin D3 and high-fat diet in rats through modulating lipid metabolism, oxidative stress, and endothelial vascular injury. J Appl Microbiol. 2023;134(8):lxad165. doi:10.1093/jambio/lxad165
   PubMed Web of Science ®Google Scholar
• Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD. Targeting Early Atherosclerosis: a Focus on Oxidative Stress and Inflammation. Oxid Med Cell Longev. 2019;2019:8563845. doi:10.1155/2019/8563845
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res. 2019;124(2):315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMed Web of Science ®Google Scholar
• Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ Res. 2018;122(12):1722–1740. doi:10.1161/CIRCRESAHA.118.311362
   PubMed Web of Science ®Google Scholar
• Brandsma E, Kloosterhuis NJ, Koster M, et al. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis. Circ Res. 2019;124(1):94–100. doi:10.1161/CIRCRESAHA.118.313234
   PubMed Web of Science ®Google Scholar
• Sedding DG, Boyle EC, Demandt JAF, et al. Vasa Vasorum Angiogenesis: key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease. Front Immunol. 2018;9:706. doi:10.3389/fimmu.2018.00706
   PubMed Web of Science ®Google Scholar
• Navab-Moghadam F, Sedighi M, Khamseh ME, et al. The association of type II diabetes with gut microbiota composition. Microb Pathog. 2017;110:630–636. doi:10.1016/j.micpath.2017.07.034
   PubMed Web of Science ®Google Scholar
• Schietroma M, Pessia B, Carlei F, Mariani P, Sista F, Amicucci G. Intestinal permeability and systemic endotoxemia in patients with acute pancreatitis. Ann Ital Chir. 2016;87:138–144.
   PubMed Web of Science ®Google Scholar
• Wang T, Guo R, Zhou G, et al. Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: a review. J Ethnopharmacol. 2016;188:234–258. doi:10.1016/j.jep.2016.05.005
   PubMed Web of Science ®Google Scholar
• Ge ZR, Xu MC, Huang YU, Zhang CJ, Lin JE, Ruan CW. Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF-β1/TAK1 signaling pathway. Exp Ther Med. 2016;11(6):2341–2348. doi:10.3892/etm.2016.3222
   PubMed Web of Science ®Google Scholar
• Zhai Y, Meng X, Luo Y, et al. Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Oncotarget. 2018;9(10):9344–9363. doi:10.18632/oncotarget.24295
   PubMedGoogle Scholar
• Guo S, Xi X, Li J. Notoginsenoside R1: a systematic review of its pharmacological properties. Pharmazie. 2019;74(11):641–647. doi:10.1691/ph.2019.9534
   PubMed Web of Science ®Google Scholar
• Lei W, Yan Y, Ma Y, et al. Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway. Front Pharmacol. 2022;13:905092. doi:10.3389/fphar.2022.905092
   PubMed Web of Science ®Google Scholar
• Shi X, Yu W, Liu L, et al. Panax notoginseng saponins administration modulates pro- /anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in rats. Metab Brain Dis. 2017;32(1):221–233. doi:10.1007/s11011-016-9901-3
   PubMed Web of Science ®Google Scholar
• Arifin WN, Zahiruddin WM. Sample Size Calculation in Animal Studies Using Resource Equation Approach. Malays J Med Sci. 2017;24(5):101–105. doi:10.21315/mjms2017.24.5.11
   PubMed Web of Science ®Google Scholar
• Kim M, Sahu A, Hwang Y, et al. Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E-/- mice. Biomaterials. 2020;226:119550. doi:10.1016/j.biomaterials.2019.119550
   PubMed Web of Science ®Google Scholar
• Liu X, Xu Y, Cheng S, et al. Geniposide Combined With Notoginsenoside R1 Attenuates Inflammation and Apoptosis in Atherosclerosis via the AMPK/mTOR/Nrf2 Signaling Pathway. Front Pharmacol. 2021;12:687394. doi:10.3389/fphar.2021.687394
   PubMed Web of Science ®Google Scholar
• van der Valk FM, Bekkering S, Kroon J, et al. Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. Circulation. 2016;134(8):611–624. doi:10.1161/CIRCULATIONAHA.116.020838
   PubMed Web of Science ®Google Scholar
• Mundi S, Massaro M, Scoditti E, et al. Endothelial permeability, LDL deposition, and cardiovascular risk factors-a review. Cardiovasc Res. 2018;114(1):35–52. doi:10.1093/cvr/cvx226
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhu T, Yin YZ, Sun B. Notoginsenoside R1, a unique constituent of Panax notoginseng, blinds proinflammatory monocytes to protect against cardiac hypertrophy in ApoE-/- mice. Eur J Pharmacol. 2018;833:441–450. doi:10.1016/j.ejphar.2018.07.004
   PubMed Web of Science ®Google Scholar
• Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–1361. doi:10.1038/nature08938
   PubMed Web of Science ®Google Scholar
• Liu D, Zeng X, Li X, Mehta JL, Wang X. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Res Cardiol. 2017;113(1):5. doi:10.1007/s00395-017-0663-9
   PubMed Web of Science ®Google Scholar
• Zhang X, Gao R, Zhou Z, et al. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. J Ethnopharmacol. 2022;296:115405. doi:10.1016/j.jep.2022.115405
   PubMed Web of Science ®Google Scholar
• Zhang C, Yuan R, Li S, et al. Notoginsenoside R1 Protects against Diabetic Nephropathy through TXNIP-NLRP3 Signaling Pathway. Clin Compl Med Pharmacol. 2023;3(4):100100. doi:10.1016/j.ccmp.2023.100100
   Google Scholar
• Horio E, Kadomatsu T, Miyata K, et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol. 2014;34(4):790–800. doi:10.1161/ATVBAHA.113.303116
   PubMed Web of Science ®Google Scholar
• Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol. 2016;84:1–7. doi:10.1016/j.vph.2016.05.013
   PubMed Web of Science ®Google Scholar
• Fu C, Yin D, Nie H, Sun D. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132. Cell Physiol Biochem. 2018;51(4):1739–1750. doi:10.1159/000495677
   PubMedGoogle Scholar
• Su P, Du S, Li H, Li Z, Xin W, Zhang W. Notoginsenoside R1 inhibits oxidized low-density lipoprotein induced inflammatory cytokines production in human endothelial EA.hy926 cells. Eur J Pharmacol. 2016;770:9–15. doi:10.1016/j.ejphar.2015.11.040
   PubMed Web of Science ®Google Scholar
• Witkowski M, Weeks TL, Hazen SL. Gut Microbiota and Cardiovascular Disease. Circ Res. 2020;127(4):553–570. doi:10.1161/CIRCRESAHA.120.316242
   PubMed Web of Science ®Google Scholar
• Pieczynska MD, Yang Y, Petrykowski S, Horbanczuk OK, Atanasov AG, Horbanczuk JO. Gut Microbiota and Its Metabolites in Atherosclerosis Development. Molecules. 2020;25(3):594. doi:10.3390/molecules25030594
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang N, Tan HY, et al. Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin-mediated AMPKα/STAT3 signaling in diet-induced obesity. Theranostics. 2020;10(24):11302–11323. doi:10.7150/thno.47746
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066–9071. doi:10.1073/pnas.1219451110
   PubMed Web of Science ®Google Scholar
• Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice. Circulation. 2016;133(24):2434–2446. doi:10.1161/CIRCULATIONAHA.115.019645
   PubMed Web of Science ®Google Scholar
• Fan J, Wang Y, You Y, et al. Fermented ginseng improved alcohol liver injury in association with changes in the gut microbiota of mice. Food Funct. 2019;10(9):5566–5573. doi:10.1039/c9fo01415b
   PubMed Web of Science ®Google Scholar